APP-FUBINACA is an indazole-based synthetic cannabinoid that has been sold online as a designer drug. Pharmacological testing showed APP-FUBINACA to have only moderate affinity for the CB1 receptor, with a Ki of 708 nM, while its EC50 was not tested.It contains a phenylalanine amino acid residue in its structure.
It’s cannabinoid class and analog of AB-Fubinaca
The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.